Colorectal Tumor
12
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
Clinical Database of Colorectal Robotic Surgery
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer
Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery
Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor
ANC1 Study Impact of a Geriatric and Nutritional Evaluation for the Malnutrition and Malnutrition Risk Screening in Patients Over 70 Years With Colorectal Surgery.
Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection
Preoperative Assessment of Colon Tumor